The panel will discuss the Canadian Competition Bureau's Updated Intellectual Property Enforcement Guidelines and approach to pharmaceutical issues, including reverse payments and product hopping. The discussion will compare and contrast the Canadian approach with that of the U.S. antitrust agencies and courts.
Leigh Oliver, Hogan Lovells
Alan Gunderson, Canadian Competition Bureau
Robert Davis, Esq., Venable LLP
Navin Joneja, Blakes
Michael Kades, Federal Trade Commission
For more information, please visit the American Bar Association website.